UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
HOWL holding history
Werewolf Therapeutics, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
HOWL overviewAll 13F holders of HOWLFull Q2 2026 holdings
- Shares (Q2 2026)
- 215,838
- Value
- $77.7K
- % of portfolio
- <0.1%
- Quarters held
- 21
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 215,838 | $77.7K | <0.1% | +148,981+222.8% | Added | Holders |
| Q1 2026 | 66,857 | $55.7K | <0.1% | +6,149+10.1% | Added | Holders |
| Q4 2025 | 60,708 | $38.4K | <0.1% | +47,932+375.2% | Added | Holders |
| Q3 2025 | 12,776 | $25.2K | <0.1% | +9,338+271.6% | Added | Holders |
| Q2 2025 | 3,438 | $3.75K | <0.1% | −14,250−80.6% | Reduced | Holders |
| Q1 2025 | 17,688 | $17.2K | <0.1% | −12,805−42.0% | Reduced | Holders |
| Q4 2024 | 30,493 | $45.1K | <0.1% | +15,014+97.0% | Added | Holders |
| Q3 2024 | 15,479 | $32.8K | <0.1% | +5,671+57.8% | Added | Holders |
| Q2 2024 | 9,808 | $23.9K | <0.1% | +9,771+26,408.1% | Added | Holders |
| Q1 2024 | 37 | $240 | <0.1% | −963−96.3% | Reduced | Holders |
| Q4 2023 | 1,000 | $3.86K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 1,000 | $2.14K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 1,000 | $3.05K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 1,000 | $2.60K | <0.1% | −448−30.9% | Reduced | Holders |
| Q4 2022 | 1,448 | $2.97K | <0.1% | −1,002−40.9% | Reduced | Holders |
| Q3 2022 | 2,450 | $11.0K | <0.1% | −1,807−42.4% | Reduced | Holders |
| Q2 2022 | 4,257 | $18.0K | <0.1% | +2,154+102.4% | Added | Holders |
| Q1 2022 | 2,103 | $9.00K | <0.1% | −7,356−77.8% | Reduced | Holders |
| Q4 2021 | 9,459 | $113.0K | <0.1% | +7,820+477.1% | Added | Holders |
| Q3 2021 | 1,639 | $28.0K | <0.1% | +639+63.9% | Added | Holders |
| Q2 2021 | 1,000 | $17.0K | <0.1% | +1,000 | New | Holders |